Homocysteine modulates sodium channel currents in human atrial myocytes

Toxicology

Volumn 256, Issue 3, 2009, Pages 201-206

  Cai, Benzhi ^a,b   Shan, Luchen ^a,b   Gong, Dongmei ^a,b   Pan, Zhenwei ^a,b   Ai, Jing ^a,b   Xu, Changqing ^a,b   Lu, Yanjie ^a,b   Yang, Baofeng ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Key Laboratory   (China)

Author keywords

Atrial myocytes; Homocysteine; Patch clamp technique; Sodium currents

Indexed keywords

HOMOCYSTEINE; SODIUM CHANNEL;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; HEART ATRIUM; HEART DEPOLARIZATION; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE STEADY POTENTIAL; PATCH CLAMP; PRIORITY JOURNAL; SODIUM CURRENT;

CELL MEMBRANE; CELLS, CULTURED; HEART ATRIA; HOMOCYSTEINE; HUMANS; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; SODIUM CHANNELS; TIME FACTORS;

EID: 58349114427     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.11.020     Document Type: Article

References (26)

1. Ay H., Arsava E.M., Tokgözoglu S.L., Ozer N., and Saribas O. Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation. Stroke 34 (2003) 909-912
2. Barajas-Martínez H.M., Hu D., Cordeiro J.M., Wu Y., Kovacs R.J., and Meltser H. Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel. Circ. Res. 103 (2008) 396-404
3. Boysen G., Brander T., Christensen H., Gideon R., and Truelsen T. Homocysteine and risk of recurrent stroke. Stroke 34 (2003) 1258-1261
4. Cai B.Z., Gong D.M., Liu Y., Pan Z.W., Xu C.Q., and Bai Y.L. Homocysteine inhibits potassium channels in human atrial myocytes. Clin. Exp. Pharmacol. Physiol. 34 (2007) 51-55
5. + currents blocked and impaired by homocysteine in human and rat mesenteric artery smooth muscle cells. Life Sci. 80 (2007) 2060-2066
6. Clarke R., and Lewington S. Homocysteine and coronary heart disease. Semin. Vasc. Med. 2 (2002) 391-399
7. Feng J.L., Wang Z., Li G.R., and Nattel S. Effects of class III antiarrhythmic drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes. J. Pharmacol. Exp. Ther. 281 (1997) 384-392
8. Fukuda K., Davies S.S., Nakajima T., Ong B.H., Kupershmidt S., and Fessel J. Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ. Res. 97 (2005) 1262-1269
9. 2+ currents between myocytes from human atrial right appendage and atrial septum. Cell. Physiol. Biochem. 21 (2008) 385-394
10. Hu D., Viskin S., Oliva A., Carrier T., Cordeiro J.M., and Barajas-Martinez H. Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction. Heart Rhythm. 4 (2007) 1072-1080
11. Huhta J.C., and Hernandez-Robles J.A. Homocysteine, folate, and congenital heart defects. Fetal. Pediatr. Pathol. 24 (2005) 71-79
12. Joseph J., Washington A., Joseph L., Koehler L., Fink L., and Hauer-Jensen M. Hyperhomocysteinemia leads to adverse cardiac remodeling and dysfunction in hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H2567-H2574
13. Joseph J., Joseph L., Shekhawat N., Devi S., Wang J., and Melchert R. Hyperhomocysteinemia leads to pathologic ventricular hypertrophy in normotensive rats. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H679-H686
14. Makita N., Mochizuki N., and Tsutsui H. Absence of a trafficking defect in R1232W/T1620M, a double SCN5A mutant responsible for Brugada syndrome. Circ. J. 72 (2008) 1018-1019
15. Marcucci R., Betti I., Cecchi E., Poli D., Giusti B., and Fedi S. Hyperhomocysteinemia and vitamin B6 deficiency: new risk markers for nonvalvular atrial fibrillation?. Am. Heart J. 148 (2004) 456-461
16. Pacher P., Ungvari Z., and Kecskemeti V. Electrophysiological effects of homocysteine in isolated rat right ventricular papillary muscles and left atria. Gen. Pharmacol. 32 (1999) 439-443
17. Pinet C., Le Grand B., John G.W., and Coulombe A. Thrombin facilitation of voltage-gated sodium channel activation in human cardiomyocytes: implications for ischemic sodium loading. Circulation 106 (2002) 2098-2103
18. Poddar R., Sivasubramanian N., DiBello P.M., Robinson K., and Jacobsen D.W. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103 (2001) 2717-2723
19. + overload-induced mitochondrial damage in the ischemic heart. Can. J. Physiol. Pharmacol. 82 (2004) 1033-1043
20. Tyagi S. Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. Am. J. Physiol. 274 (1998) C396-C405
21. Ver Donck L., Borgers M., and Verdonck F. Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle. Cardiovasc. Res. 27 (1993) 349-357
22. + current similar to Kv1. 5 cloned channel currents. Circ. Res. 73 (1993) 1061-1076
23. Wang Z., Fermini B., and Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc. Res. 281 (1994) 1540-1546
24. Watanabe H., Koopmann T.T., Le Scouarnec S., Yang T., Ingram C.R., and Schott J.J. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J. Clin. Invest. 118 (2008) 2260-2268
25. Williams I.A., Xiao X.H., Ju Y.K., and Allen D.G. The rise of [Na(+)](i) during ischemia and reperfusion in the rat heart-underlying mechanisms. Pflugers. Arch. 454 (2007) 903-912
26. + current in guinea pig ventricular myocytes. Acta Pharmacol. Sinica 19 (1998) 269-272